Deep, specific future-era sequencing has unveiled that subclonal mutations (i.e., These existing in only a portion of tumor cells) can be detected for all driver genes and so are connected with swift sickness development and weak outcome.11–13 This is particularly pertinent for TP53 mutations provided The truth that, as discussed under, CLL thera